Primary Record
Odanacatib
- In stock
- 2,306 g
- Purity
- 99.1 %
- CAS
- 603139-19-1
Compound Identifiers & Properties
- CAS
- 603139-19-1
- PubChem CID
- 10152654
- SMILES
- CC(C)(C[C@@H](C(=O)NC1(CC1)C#N)N[C@@H](C2=CC=C(C=C2)C3=CC=C(C=C3)S(=O)(=O)C)C(F)(F)F)F
- Canonical SMILES
- CC(C)(F)C[C@H](N[C@@H](c1ccc(-c2ccc(S(C)(=O)=O)cc2)cc1)C(F)(F)F)C(=O)NC1(C#N)CC1
Names & Synonyms
- Odanacatib
- 603139-19-1
- Odanacatib (MK-0822)
- odanacatibum
- Odanacatinib
- MK-0822
- MK0822
- Odanacatib [USAN]
- Odanacatib (MK0822)
- Odanacatib (USAN)
- zlchem 324
- Odanacatib [USAN:INN]
- ODANACATIB [MI]
- Odanacatib (MK 0822)
- ODANACATIB [INN]
- ODANACATIB [JAN]
- Odanacatib (JAN/USAN)
- RefChem:856152
- N673F6W2VH
- UNII-N673F6W2VH
- C25H27F4N3O3S
- MK 0822
- D0J6AU
- ODANACATIB [MART.]
- CHEMBL481611
- ODANACATIB [WHO-DD]
- MFCD11042419
- MLS006010197
- DTXSID40209075
- 603139-19-1Topotecan
- FWIVDMJALNEADT-SFTDATJTSA-N
- GTPL6478
- orb1301131
- SCHEMBL1496266
- MK-0822A
- A10BH01
- DTXCID60131566
- EX-A552
- ZLC0158
- BCPP000141
- cas:603139-19-1;Odanacatib
- KS-00001CN1
- ABP000250
- BDBM50255753
- NSC766811
- s1115
- ZINC42893657
- AKOS015900719
- L-1037536
- BCP9001020
- CCG-269888
- CS-0277
- DB06670
- FM65088
- NSC-766811
- CID10152654
- NCGC00346637-01
- NCGC00346637-08
- NCGC00346637-11
- AC-27468
- AN-16836
- AS-19562
- BC623052
- CID 10152654
- HY-10042
- SC-69096
- SMR004676504
- AB0007971
- A2487
- NS00072488
- Odanacatib,MK-0822,MK0822/MK-0822
- SW219669-1
- Y0388
- J2.625.695J
- L-001037536
- A11265
- D08955
- MK-0822;MK 0822;MK0822
- Q-4474
- (S)-N-(1-cyanocyclopropyl)-4-fluoro-4-methyl-2-(((S)-2,2,2-trifluoro-1-(4'-(methylsulfonyl)-[1,1'-biphenyl]-4-yl)ethyl)amino)pentanamide
- 139M191
- A854381
- (2S)-N-(1-cyanocyclopropyl)-4-fluoro-4-methyl-2-[[(1S)-2,2,2-trifluoro-1-[4-(4-methylsulfonylphenyl)phenyl]ethyl]amino]pentanamide
- Q2014070
- BRD-K22822991-001-02-3
- I14-16378
- B0084-095375
- (2S)-N-(1-Cyanocyclopropyl)-4-fluoro-4-methyl-2-[[(1S)-2,2,2-trifluoro-1-[4'-(methylsulfonyl)[1,1'-biphenyl]-4-yl]ethyl]amino]pentanamide
- (2S)-N-(1-Cyanocyclopropyl)-4-fluoro-4-methyl-2-(((1S)-2,2,2-trifluoro-1-(4'-(methylsulfonyl)(1,1'-biphenyl)-4-yl)ethyl)amino)pentanamide
- (S)-N-(1-CYANOCYCLOPROPYL)-4-FLUORO-4-METHYL-2-((S)-2,2,2-TRIFLUORO-1-(4'-(METHYLSULFONYL)BIPHENYL-4-YL)ETHYLAMINO)PENTANAMIDE
- (2S)-4-Fluoro-2-[[(1S)-2,2,2-trifluoro-1-(4 -methylsulfonyl-4-biphenylyl)ethyl]amino]-N-(1-cyanocyclopropyl)-4-methylpentanamide
- (2S)-N-(1-Cyanocyclopropyl)-2-[[(1S)-1-[4 -(methylsulfonyl)-4-biphenylyl]-2,2,2-trifluoroethyl]amino]-4-fluoro-4-methylpentanamide
- (2S)-N-(1-Cyanocyclopropyl)-2-[[(S)-1-[4 -(methylsulfonyl)-1,1 -biphenyl-4-yl]-2,2,2-trifluoroethyl]amino]-4-fluoro-4-methylpentanamide
- (2S)-N-(1-cyanocyclopropyl)-4-fluoro-4-methyl-2-(((1S)-2,2,2-trifluoro-1-(4'-methanesulfonyl-(1,1'-biphenyl)-4-yl)ethyl)amino)pentanamide
- (2S)-N-(1-cyanocyclopropyl)-4-fluoro-4-methyl-2-(((1S)-2,2,2-trifluoro-1-(4-(4-methylsulfonylphenyl)phenyl)ethyl)amino)pentanamide
- (2S)-N-(1-cyanocyclopropyl)-4-fluoro-4-methyl-2-{[(1S)-2,2,2-trifluoro-1-[4-(4-methanesulfonylphenyl)phenyl]ethyl]amino}pentanamide
- (2S)-N-(1-cyanocyclopropyl)-4-fluoro-4-methyl-2-{[(1S)-2,2,2-trifluoro-1-{4'-methanesulfonyl-[1,1'-biphenyl]-4-yl}ethyl]amino}pentanamide
- 603139-12-4
- N-(1-Cyanocyclopropyl)-4-fluoro-N~2~-{(1S)-2,2,2-trifluoro-1-[4'-(methanesulfonyl)[1,1'-biphenyl]-4-yl]ethyl}-L-leucinamide
- N-(1-Cyanocyclopropyl)-4-fluoro-N2-{(1S)-2,2,2-trifluoro-1-[4'-(methylsulfonyl)biphenyl-4-yl]ethyl}-L-leucinamide
- N1-(1-cyanocyclopropyl)-4-fluoro-N2-{(1S)-2,2,2-trifluoro-1-[4'-(methyl sulfonyl)-1,1'-biphenyl-4-yl]ethyl}-L-leucinamide
- N1-(1-cyanocyclopropyl)-4-fluoro-N2-{(1S)-2,2,2-trifluoro-1-[4'-(methylsulfonyl)-1,1'-biphenyl-4-yl]ethyl}-L-leucinamide
- Pentanamide, N-(1-cyanocyclopropyl)-4-fluoro-4-methyl-2-(((1S)-2,2,2-trifluoro-1-(4'-(methylsulfonyl)(1,1'-biphenyl)-4-yl)ethyl)amino)-, (2S)-